Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Jan 03, 2012 Nature speaks with Keim about H5N1 studies Tags: h5n1, northern arizona university, paul keim, tgen north -
-
-
Jun 20, 2011 Promising skin-cancer drug nears approval Tags: daniel von hoff, scottsdale healthcare, tgen
Drug used in stroke patients might also improve learning and memory, while reducing the risk of Alzheimer’s disease, TGen and ASU researchers find
Tags: arizona state university, neuroscience, tgen[Source: TGen] - A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a new study released today by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University.
Fasudil has been used for more than 10 years to help protect the brain in stroke patients by dilating blood vessels when blood flow is curtailed.
Now, a team of Arizona psychologists, geneticists and neuroscientists report in today’s edition of the journal Behavioral Neuroscience that hydroxyfasudil, the active form of the parent drug Fasudil, improved spatial learning and working memory in middle-aged rats when negotiating a complicated maze.
The findings suggest that hydroxyfasudil may influence similar cognitive processes in humans involving the hippocampus, a part of the brain that has been shown to deteriorate in patients with age-related disorders.
For more information click here.
Quick Links
![]()
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.


Share on Twitter
Share on Facebook


